Advertisement

Topics

Companies Related to "deCODE genetics Mergers Acquisitions Partnerships Alliances Investment Report" [Most Relevant Company Matches] RSS

08:19 EST 23rd November 2017 | BioPortfolio

Here are the most relevant search results for "deCODE genetics Mergers Acquisitions Partnerships Alliances Investment Report" found in our extensive corporate database of over 50,000 company records.

Showing "deCODE genetics Mergers Acquisitions Partnerships Alliances Investment Report" Companies 1–25 of 2,300+

Extremely Relevant

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE's unique gene discovery and drug development capabilities to an even larger set of population-based resources.


Relevant

Intrepid Investment Bankers LLC

Intrepid Investment Bankers LLC, based in Los Angeles, California, is a mergers and acquisitions and corporate finance advisory firm focused on the middle-market. Intrepid was founded in 2010 by the former principals of Barrington Associates, a firm that grew to become a leading national middle market M&A advisor before its acquisition by Wells Fargo in 2006. ...

E. J. McKay

E. J. McKay is a Shanghai based investment banking group specialized in structuring complex cross-border mergers & acquisitions and merchant banking transactions. Through its offices and strategic partnerships, the firm is present in thirty major financial centers around the world. E. J. McKay has a dedicated focus on China, and advises transactions both inbound and outbound, representing clie...


MedTech Capital, Inc.

MedTech Capital, Inc., founded in 1990, is a private Investment Banking Firm based in Boston, Massachusetts specializing in corporate financial services for middle market and emerging growth companies in the Health Care and Medical Technology businesses.Our areas of special interest and expertise are:Mergers & Acquisitions Corporate Partnerships Joint Ventures Private Placements

deCode

Based in Reykjavik, Iceland, deCODE genetics is a population-based genomics company conducting research into the inherited causes of common diseases. The company operates one of the most technologically advanced high-throughput genotyping laboratories in the world. Together with pharmaceutical companies and other healthcare institutions, deCODE aims to utilize its research to develop new methods f...

TripleTree LLC

TripleTree is an independent, research-driven investment bank focused on mergers and acquisitions, financial restructuring, and principal investing services. For more than a decade, the firm has worked with innovative, high-growth businesses in the healthcare industry. www.triple-tree.com

deCODE genetics

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the bas...

Cleary Gull

Cleary Gull (www.clearygull.com) is an employee-owned firm headquartered in Milwaukee, Wisconsin providing specialized financial services through two operating divisions: Investment Advisory and Investment Banking. Cleary Gull has combined assets under management of $2.5 billion as of June 30, 2013 and focuses on high net worth individuals, pilots, and not...

The Cockrell Group

The Cockrell Group, Inc. is a strategic investor relations and corporate access firm focused on small-to-midcap companies in healthcare. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in various areas, including private and pr...

Marcum Cronus Partners

Advising on mergers, acquisitions, divestitures, sales, and private placement financings, Marcum Cronus Partners is an investment banking firm that provides financial advisory and other investment banking services. The clients of the firm are publicly traded or privately owned companies that engage in middle-market transactions domestically or internationa...

TL Ventures

With over $1.4 billion under management, we have been actively engaged in the business of venture capital since 1988, investing in over 200 companies to date. Our network of approximately 50 active portfolio companies, investment resources, professional contacts and service providers makes us one of the most active firms in the market.TL Ventures invests in companies led by outstanding management ...

TripleTree, LLC

TripleTree, LLC is an independent, merchant and investment bank focused on mergers and acquisitions, financial restructuring, principal investing, and strategic advisory services for healthcare and technology companies. The firm specializes in growth businesses, vertical industry specialization, and disruptive technology delivery models.

Lazard

Lazard Ltd began trading on the New York Stock Exchange on May 5, 2005 under the ticker symbol "LAZ". Lazard, the world's preeminent advisory investment bank, has offices in 16 countries around the globe. With origins dating back to 1848, the firm provides advisory services including mergers and acquisitions, asset management, and restructuring to corporations, partnerships, institutions, governme...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, counseling, and support services. By providing valuable insight into the genetics of disease, AccessDNA helps people better understand their treatment, management and prevention option...

Madison Keats

Madison Keats provides our highly specialized investment banking services for a select clientele drawn solely from the life sciences industry. For those developing new products and technologies-and those seeking to identify them-Madison Keats is an invaluable partner, providing strategic support via our Licensing, Mergers and Acquisitions, Private Placement and Business Valuation services.

Biotech Sage

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While our email updates focuses on news events, scientific advancements or biotechnology opportunities. Our goal is to provide valuable information to assist you in your investment strategies. The aim of BioT...

Dresdner Kleinwort Benson

Dresdner Kleinwort Wasserstein (DrKW), the investment banking division of Dresdner Bank, a member of the Allianz Group, provides a wide range of investment bank products and services to European and international clients including corporates, institutions and governments.We provide a full array of advisory and capital markets products including mergers & acquisitions (M&A) and advisory services, e...

AllianCat Tschannen - Pharma Research & Licensing Consultants

AllianCat delivers professional support to companies in the pharmaceutical, biotechnology and chemical arena by providing services for business development and licensing. The objective is to optimize the economic value of innovation by establishing solid partnerships in growth markets. These partnerships range from patent and know-how licensing to research, development and marketing alliances in a...

AR BioConsultants

AR BioConsultants provides technical, regulatory and commercial advice in the biotechnology sector. Particular areas of expertise include cell therapy, encapsulation technology, tissue engineering and stem cells. Investments, partnerships, acquisitions, mergers and IPOs are some of the important decisions in the biotechnology sector and they all require a critical evaluation of the science and tec...

deCODE chemistry

deCODE chemistry offers chemistry-based drug discovery and development services including early-stage lead discovery and optimization, process chemistry research for development of optimal synthetic routes, and cGMP production of materials in quantities for pre-clinical and clinical studies. Additionally, deCODE chemistry now offers services for evaluation of pharmaceutical properties including ra...

Raymond James Health Care Investment Banking Group

In terms of domain expertise, dedicated resources, and transaction track record, the Health Care Investment Banking Group of Raymond James & Associates is one of the oldest, largest, and most successful health care-focused advisory services practices in the United States. The Group provides a broad range of advisory and capital raising services to companie...

Lazard Ltd

Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 43 cities across 27 countries in North America, Europe, Asia, Australia, Central and South America. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and ...

Houlihan Lokey

Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm is ranked globally as the No. 1 restructuring advisor, the No. 1 M&A fairness opinion advisor over the past 10 years, and the No. 1 M&A advisor for U.S. transactions under $1 billion, accord...

Yukon Partners

Yukon Partners (www.yukonpartners.com) is a mezzanine finance firm dedicated to serving middle market private equity sponsored business transactions with a typical investment range of $10 to $40 million in the U.S. and Canada. The transactions in which Yukon invests include Buyouts, Growth and Platform Strategies, Recapitalizations, Mergers/Acquisitions, P...


More From BioPortfolio on "deCODE genetics Mergers Acquisitions Partnerships Alliances Investment Report"

Quick Search
Advertisement
 

Corporate Database Quicklinks